Fuse Oncology has filed a notice of an exempt offering of securities to raise $8,860,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Fuse Oncology is raising $8,860,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, James Bauler played a key role…